Subscribe today - find out more
Why you should consider BusinessDesk
Listed Companies

David Darling has a dig at DHB delays

Brent Melville
Mon, 26 Jul 2021

David Darling: Disappointed with slow adoption (Image: Supplied)
Brent Melville
Mon, 26 Jul 2021
Pacific Edge’s cancer diagnostic products have made headway into the US healthcare sector over the past several years, but many New Zealand patients continue to be shut out by the bureaucracy of local DHBs, the company says.Last June, the NZX-listed firm announced giant US healthcare group Kaiser Permanente had approved its Cxbladder products for use by urologists to monitor patients for bladder cancer. A month later it announced Cxbladder tests will be covered by the Centers for Medicare and Medicaid Services (CMS) across the US mar...

Use the information you’ve already given Google to create your subscription.

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Opinion
The hermit trading nation
Ian McCrae | Sat, 25 Sep 2021

The rest of the world is opening up, and NZ businesses' international customers are getting frustrated. 

Law & Regulation
Deloitte: Why consultants are moving into advertising
Daniel Dunkley | Sat, 25 Sep 2021

The glamorous advertising world looks set for a shake-up.

On the Money
On the Money: Judith Collins, Ardie Savea, NZ's most accessible business leaders, and more
Rebecca Stevenson | Sat, 25 Sep 2021

OTM this week: the parallels between Judith Collins' business and political careers, who are the most approachable business leaders in NZ, which company is holding fire to get personal? And more.

Sponsored
Demand driven change an easier route to carbon reduction

Taking a demand-driven approach to carbon reduction will naturally bring us into line with government targets.

Sponsored
Kiwi security technology leading the world

Businesses must take advantage of our home-grown, world-leading, internationally-valued cyber defence systems to manage risk.